Investment
Features
FeesSafety
Academy
More
Pluang+

U.S. Air Force funds Virtuix's AI-powered VR terrain system for immersive military mission planning

Market News
27 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Virtuix, Inc. has been selected by the U.S. Air Force for Phase I funding under the AFWERX SBIR program to develop its Virtual Terrain Walk (VTW) platform. This system uses omni-directional treadmills, AI-driven 3D terrain reconstruction, and immersive XR environments to allow soldiers to physically navigate virtual replicas of real-world battlefields for mission planning and tactical rehearsals. The technology supports collaborative planning for teams of 12 or more, enhancing readiness by enabling warfighters to familiarize themselves with terrain before deployment. The Phase I award could lead to over $1 million in Phase II funding and further government contracts, reflecting growing demand for AI-enabled immersive military training solutions.

More News

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

Investors in Putnam mutual funds may claim losses in a new class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...

Market News
Bearish
1 hour ago
Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Stocks fall sharply due to legal probes, financing plans, and volatile listings today.

Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...

Market News
Bearish
2 hours ago
Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

Study finds 2 years of lenalidomide maintenance as effective as indefinite treatment for multiple myeloma.

The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...

Company Fundamentals
Neutral
2 hours ago
Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

Stock market jumps on strong corporate news and high trading volumes in EV and green energy sectors

The stock market saw significant gains driven by corporate announcements and high trading volumes, particularly in battery technology, electric vehicles, and green energy sectors. Electrovaya surged 49.05% after announcing a commercial deal with Amaz...

Market News
Bullish
2 hours ago
Akamai officer sells shares amid shift to cloud and cybersecurity growth

Akamai officer sells shares amid shift to cloud and cybersecurity growth

An Akamai Technologies executive sold 3,100 shares as the company shifts focus from its declining content delivery network business to high-growth cloud infrastructure and cybersecurity services. This strategic pivot is supported by a $1.8 billion, s...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App